Next-gen ultrasound system to be unveiled at AIUM 2018

26th March 2018
Posted By : Enaie Azambuja
Next-gen ultrasound system to be unveiled at AIUM 2018

Samsung NeuroLogica, a subsidiary of Samsung Electronics Co. Ltd., has announced that the Samsung RS85A ultrasound system has received FDA 510(k) clearance and will be unveiled at the American Institute of Ultrasound in Medicine (AIUM) in New York City. The RS85A is the latest expansion of Samsung’s revolutionary ultrasound portfolio. “The RS85A embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of access, accuracy and efficiency.”

“We are pleased to launch the RS85A, a new premium general imaging ultrasound system with superior image quality and usability based on Samsung’s advanced ultrasound and radiology technologies,” said Philip Sullivan, President and CEO of Samsung NeuroLogica.

“The RS85A embodies Samsung’s commitment to providing leading technologies to healthcare providers by combining our key values of access, accuracy and efficiency.”

The release of the RS85A is the latest demonstration of Samsung’s leadership in ultrasound. It features an array of improvements, including:

  • MV-Flow: Allows for visualisation of slow-flow micro vascularised structures, which can be difficult to assess with conventional power Doppler ultrasound. It also provides clinicians an additional way to check lesions for indications of cancer or inflammation.
  • S-Shearwave Imaging: Provides new indicators for clinical diagnosis by quantifying the elasticity of tissue or lesions via shearwave elastography, which may help increase the accuracy of diagnosis for breast and liver diseases.
  • CEUS+: Diagnoses and characterises lesions in the liver using a contrast agent in adult and pediatric populations.
  • S-Fusion: Enables simultaneous localisation of a lesion using real-time ultrasound in conjunction with other volumetric imaging modalities such as an MRI or a CT, while expanding its capabilities to the prostate gland for precise, targeted biopsy guidance.

The RS85A was also developed to help decrease user-fatigue and repetitive motions with an enhanced monitor arm and increased range of motion and tilt. These improvements allow the user to position the monitor for optimal viewing and control. Additionally, multi-step actions have been combined into a single step to help reduce keystrokes and repetitive user interface interactions.

“Samsung has built innovative and cutting-edge diagnostic ultrasound products for more than 30 years,” said David Legg, Vice President of Sales at Samsung NeuroLogica. “We are so confident that our RS85A ultrasound system will perform reliably and be the system that you can depend on for years to come, that we are proud to offer a 5-year warranty standard, at no additional cost.”

In addition to the introduction of the RS85A at AIUM 2018, Samsung will showcase additional products in their comprehensive ultrasound portfolio, including the WS80A with Elite, our premium women’s health ultrasound system, the HS60, HS40 and the HM70A with Plus.


You must be logged in to comment

Write a comment

No comments




More from Samsung Electronics Co., Ltd.

Sign up to view our publications

Sign up

Sign up to view our downloads

Sign up

Hannover Fair 2019
1st April 2019
Germany Hannover
The Security Event 2019
9th April 2019
United Kingdom NEC, Birmingham
Ceramics Expo 2019
29th April 2019
United States of America International Exposition Center (I-X Center)
Electronics & Applications 2019
14th May 2019
Netherlands Jaarbeurs Utrecht Hall 7 Jaarbeursplein
Agile for Automotive 2019
15th May 2019
United States of America Detroit, MI